# Olive Oil and Nampt on Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome

> **NCT02061267** · NA · COMPLETED · sponsor: **National Research Council, Spain** · enrollment: 40 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Niacin
- **DIETARY_SUPPLEMENT:** Saturated meal
- **DIETARY_SUPPLEMENT:** Monounsaturated meal
- **DIETARY_SUPPLEMENT:** Polyunsaturated meal

## Key facts

- **NCT ID:** NCT02061267
- **Lead sponsor:** National Research Council, Spain
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-01
- **Primary completion:** 2013-12
- **Final completion:** 2015-06-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02061267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02061267, "Olive Oil and Nampt on Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02061267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*